The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan

INTRODUCTION: Many articles have reported that the coronavirus disease 2019 (COVID-19) causes coagulation abnormalities and pulmonary thrombosis, contributing to a poorer prognosis. The study aimed to evaluate whether pre-admission anticoagulation and antiplatelet therapy prevented severe COVID-19 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Togano, Tomiteru, Uemura, Yukari, Asai, Yusuke, Hayakawa, Kayoko, Matsunaga, Nobuaki, Terada, Mari, Ohtsu, Hiroshi, Suzuki, Setsuko, Toyoda, Ako, Hara, Hisao, Sato, Rubuna, Ishikane, Masahiro, Kinoshita-Iwamoto, Noriko, Hangaishi, Akira, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302845/
https://www.ncbi.nlm.nih.gov/pubmed/34340930
http://dx.doi.org/10.1016/j.jiac.2021.07.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302845/
https://www.ncbi.nlm.nih.gov/pubmed/34340930
http://dx.doi.org/10.1016/j.jiac.2021.07.016

Ejemplares similares